TETSUO ASHIZAWA to Male
This is a "connection" page, showing publications TETSUO ASHIZAWA has written about Male.
Connection Strength
0.883
-
Analysis of diffusion tensor parameters in spinocerebellar ataxia type 3 and type 10 patients. Parkinsonism Relat Disord. 2020 09; 78:73-78.
Score: 0.029
-
Cancer frequency in patients with spinocerebellar ataxia type 10. Parkinsonism Relat Disord. 2020 07; 76:1-2.
Score: 0.029
-
Clinical and Genetic Evaluation of Spinocerebellar Ataxia Type 10 in 16 Brazilian Families. Cerebellum. 2019 Oct; 18(5):849-854.
Score: 0.027
-
Spinocerebellar ataxias in Southern Brazil: Genotypic and phenotypic evaluation of 213 families. Clin Neurol Neurosurg. 2019 Sep; 184:105427.
Score: 0.027
-
Inheritance patterns of ATCCT repeat interruptions in spinocerebellar ataxia type 10 (SCA10) expansions. PLoS One. 2017; 12(4):e0175958.
Score: 0.023
-
SPG7 and Impaired Emotional Communication. Cerebellum. 2017 04; 16(2):595-598.
Score: 0.023
-
SMRT Sequencing of Long Tandem Nucleotide Repeats in SCA10 Reveals Unique Insight of Repeat Expansion Structure. PLoS One. 2015; 10(8):e0135906.
Score: 0.021
-
Clinical characteristics of patients with spinocerebellar ataxias 1, 2, 3 and 6 in the US; a prospective observational study. Orphanet J Rare Dis. 2013 Nov 13; 8:177.
Score: 0.018
-
Spinocerebellar ataxia type 10: from Amerindians to Latin Americans. Curr Neurol Neurosci Rep. 2013 Nov; 13(11):393.
Score: 0.018
-
Purkinje cell loss is the major brain pathology of spinocerebellar ataxia type 10. J Neurol Neurosurg Psychiatry. 2013 Dec; 84(12):1409-11.
Score: 0.018
-
Generation of neural cells from DM1 induced pluripotent stem cells as cellular model for the study of central nervous system neuropathogenesis. Cell Reprogram. 2013 Apr; 15(2):166-77.
Score: 0.017
-
Generation of human-induced pluripotent stem cells to model spinocerebellar ataxia type 2 in vitro. J Mol Neurosci. 2013 Oct; 51(2):237-48.
Score: 0.017
-
GGCCTG repeats put a hex on Purkinje cells and motor neurons in SCA36. Neurology. 2012 Jul 24; 79(4):302-3.
Score: 0.017
-
Ethnic origin and extrapyramidal signs in an Argentinean spinocerebellar ataxia type 10 family. Neurology. 2007 Jul 10; 69(2):216-8.
Score: 0.012
-
The impact of interrupted ATXN10 expansions on clinical findings of spinocerebellar ataxia type 10. J Neurol. 2025 Mar 11; 272(4):261.
Score: 0.010
-
Spinocerebellar Ataxia Progression Measured with the Patient-Reported Outcome Measure of Ataxia. Mov Disord. 2025 May; 40(5):917-927.
Score: 0.010
-
ATXN10 Gene Expansions in Mexican Patients with Ataxia Without Epilepsy. Cerebellum. 2025 Jan 16; 24(2):33.
Score: 0.010
-
Sensitivity of Advanced Magnetic Resonance Imaging to Progression over Six?Months in Early Spinocerebellar Ataxia. Mov Disord. 2024 Oct; 39(10):1856-1867.
Score: 0.010
-
SARA captures disparate progression and responsiveness in spinocerebellar ataxias. J Neurol. 2024 Jul; 271(7):3743-3753.
Score: 0.009
-
Somatic and germline instability of the ATTCT repeat in spinocerebellar ataxia type 10. Am J Hum Genet. 2004 Jun; 74(6):1216-24.
Score: 0.009
-
Fatigue Impacts Quality of Life in People with Spinocerebellar Ataxias. Mov Disord Clin Pract. 2024 May; 11(5):496-503.
Score: 0.009
-
The Cerebellar Cognitive Affective/Schmahmann Syndrome Scale in Spinocerebellar Ataxias. Cerebellum. 2024 Aug; 23(4):1411-1425.
Score: 0.009
-
Screening for mutations in the MECP2 (Rett syndrome) gene in Gilles de la Tourette syndrome. Arch Neurol. 2003 Apr; 60(4):502-3.
Score: 0.009
-
Clinical features and ATTCT repeat expansion in spinocerebellar ataxia type 10. Arch Neurol. 2002 Aug; 59(8):1285-90.
Score: 0.008
-
Clinical and genomic analysis of a large Chinese family with familial cortical myoclonic tremor with epilepsy and SAMD12 intronic repeat expansion. Epilepsia Open. 2021 03; 6(1):102-111.
Score: 0.008
-
A "dystrophic" variant of autosomal recessive myotonia congenita caused by novel mutations in the CLCN1 gene. Neurology. 2000 Dec 12; 55(11):1697-703.
Score: 0.007
-
Balance and physical functioning in Spinocerebellar ataxias 3 and 10. Acta Neurol Scand. 2021 Apr; 143(4):458-463.
Score: 0.007
-
Biallelic Intronic AAGGG Expansion of RFC1 is Related to Multiple System Atrophy. Ann Neurol. 2020 12; 88(6):1132-1143.
Score: 0.007
-
Large expansion of the ATTCT pentanucleotide repeat in spinocerebellar ataxia type 10. Nat Genet. 2000 Oct; 26(2):191-4.
Score: 0.007
-
Variability and validity of polymorphism association studies in Parkinson's disease. Neurology. 2000 Aug 22; 55(4):533-8.
Score: 0.007
-
Primary coenzyme Q10 deficiency due to COQ8A gene mutations. Mol Genet Genomic Med. 2020 10; 8(10):e1420.
Score: 0.007
-
Deficiency in classical nonhomologous end-joining-mediated repair of transcribed genes is linked to SCA3 pathogenesis. Proc Natl Acad Sci U S A. 2020 04 07; 117(14):8154-8165.
Score: 0.007
-
Polymorphism of NACP-Rep1 in Parkinson's disease: an etiologic link with essential tremor? Neurology. 2000 Mar 14; 54(5):1195-8.
Score: 0.007
-
Pulse-Field capillary electrophoresis of repeat-primed PCR amplicons for analysis of large repeats in Spinocerebellar Ataxia Type 10. PLoS One. 2020; 15(3):e0228789.
Score: 0.007
-
The impact of ethnicity on the clinical presentations of spinocerebellar ataxia type 3. Parkinsonism Relat Disord. 2020 03; 72:37-43.
Score: 0.007
-
Very large (CAG)(n) DNA repeat expansions in the sperm of two spinocerebellar ataxia type 7 males. Hum Mol Genet. 1999 Dec; 8(13):2473-8.
Score: 0.007
-
Tremor in the Degenerative Cerebellum: Towards the Understanding of Brain Circuitry for Tremor. Cerebellum. 2019 Jun; 18(3):519-526.
Score: 0.007
-
Mapping of the gene for a novel spinocerebellar ataxia with pure cerebellar signs and epilepsy. Ann Neurol. 1999 Mar; 45(3):407-11.
Score: 0.007
-
Olfactory Function in SCA10. Cerebellum. 2019 Feb; 18(1):85-90.
Score: 0.007
-
The G209A mutation in the alpha-synuclein gene is not detected in familial cases of Parkinson disease in non-Greek and/or Italian populations. Arch Neurol. 1998 Dec; 55(12):1521-3.
Score: 0.006
-
Polymorphisms in DNA methylation-related genes are linked to the phenotype of Machado-Joseph disease. Neurobiol Aging. 2019 03; 75:225.e1-225.e8.
Score: 0.006
-
Body composition in Spinocerebellar ataxia type 3 and 10 patients: Comparative study with control group. Nutr Neurosci. 2020 Jan; 23(1):49-54.
Score: 0.006
-
Sleep disorders in spinocerebellar ataxia type 10. J Sleep Res. 2018 10; 27(5):e12688.
Score: 0.006
-
Antitumor activity of KW-2170, a novel pyrazoloacridone derivative. Anticancer Drugs. 1998 Mar; 9(3):263-71.
Score: 0.006
-
Nonmotor Symptoms in Patients with Spinocerebellar Ataxia Type 10. Cerebellum. 2017 Dec; 16(5-6):938-944.
Score: 0.006
-
C9orf72 repeat expansions as genetic modifiers for depression in spinocerebellar ataxias. Mov Disord. 2018 03; 33(3):497-498.
Score: 0.006
-
Dystonia and ataxia progression in spinocerebellar ataxias. Parkinsonism Relat Disord. 2017 Dec; 45:75-80.
Score: 0.006
-
Postural Tremor and Ataxia Progression in Spinocerebellar Ataxias. Tremor Other Hyperkinet Mov (N Y). 2017; 7:492.
Score: 0.006
-
A Comparative Optical Coherence Tomography Study of Spinocerebellar Ataxia Types 3 and 10. Cerebellum. 2017 08; 16(4):797-801.
Score: 0.006
-
The Initial Symptom and Motor Progression in Spinocerebellar Ataxias. Cerebellum. 2017 06; 16(3):615-622.
Score: 0.006
-
Ubiquitin-related network underlain by (CAG)n loci modulate age at onset in Machado-Joseph disease. Brain. 2017 04 01; 140(4):e25.
Score: 0.006
-
ATXN2-AS, a gene antisense to ATXN2, is associated with spinocerebellar ataxia type 2 and amyotrophic lateral sclerosis. Ann Neurol. 2016 10; 80(4):600-15.
Score: 0.006
-
[A case report of volatile solvent psychosis]. Nihon Arukoru Yakubutsu Igakkai Zasshi. 1996 Oct; 31(5):475-82.
Score: 0.006
-
Cervical dystonia as the initial presentation of Huntington's disease. Mov Disord. 1996 Jul; 11(4):457-9.
Score: 0.005
-
Sensory and motor cortex function contributes to symptom severity in spinocerebellar ataxia type 6. Brain Struct Funct. 2017 03; 222(2):1039-1052.
Score: 0.005
-
Effects of ceruletide on perioral movements and the dopamine receptor-adenylate cyclase system in rats chronically treated with fluphenazine. Psychopharmacology (Berl). 1996 Jun; 125(3):185-94.
Score: 0.005
-
Characteristics of the antitumor activity of M-16 and M-18, major metabolites of a new mitomycin C derivative KW-2149, in mice. Anticancer Drugs. 1995 Dec; 6(6):763-70.
Score: 0.005
-
High Serum GFAP Levels in SCA3/MJD May Not Correlate with Disease Progression. Cerebellum. 2015 Dec; 14(6):677-81.
Score: 0.005
-
Depression and clinical progression in spinocerebellar ataxias. Parkinsonism Relat Disord. 2016 Jan; 22:87-92.
Score: 0.005
-
Emotional and functional impact of DNA testing on patients with symptoms of Huntington's disease. J Med Genet. 1995 Jul; 32(7):516-8.
Score: 0.005
-
Analysis of the GGGGCC Repeat Expansions of the C9orf72 Gene in SCA3/MJD Patients from China. PLoS One. 2015; 10(6):e0130336.
Score: 0.005
-
De novo myotonic dystrophy mutation in a Nigerian kindred. Am J Hum Genet. 1995 May; 56(5):1067-74.
Score: 0.005
-
Clinical evaluation of eye movements in spinocerebellar ataxias: a prospective multicenter study. J Neuroophthalmol. 2015 Mar; 35(1):16-21.
Score: 0.005
-
Two novel SNPs in ATXN3 3' UTR may decrease age at onset of SCA3/MJD in Chinese patients. PLoS One. 2015; 10(2):e0117488.
Score: 0.005
-
Bolivian kindred with combined spinocerebellar ataxia types 2 and 10. Acta Neurol Scand. 2015 Aug; 132(2):139-42.
Score: 0.005
-
Tourettism associated with Huntington's disease. Mov Disord. 1995 Jan; 10(1):103-5.
Score: 0.005
-
Coenzyme Q10 and spinocerebellar ataxias. Mov Disord. 2015 Feb; 30(2):214-20.
Score: 0.005
-
Modulation of the age at onset in spinocerebellar ataxia by CAG tracts in various genes. Brain. 2014 Sep; 137(Pt 9):2444-55.
Score: 0.005
-
Spinocerebellar ataxia type 10 in Peru: the missing link in the Amerindian origin of the disease. J Neurol. 2014 Sep; 261(9):1691-4.
Score: 0.005
-
CAG repeat size and clinical presentation in Huntington's disease. Neurology. 1994 Jun; 44(6):1137-43.
Score: 0.005
-
Characteristics of intergenerational contractions of the CTG repeat in myotonic dystrophy. Am J Hum Genet. 1994 Mar; 54(3):414-23.
Score: 0.005
-
Effects of the sex of myotonic dystrophy patients on the unstable triplet repeat in their affected offspring. Neurology. 1994 Jan; 44(1):120-2.
Score: 0.005
-
Repeat interruptions in spinocerebellar ataxia type 10 expansions are strongly associated with epileptic seizures. Neurogenetics. 2014 Mar; 15(1):59-64.
Score: 0.005
-
Comprehensive phenotype of the p.Arg420his allelic form of spinocerebellar ataxia type 13. Cerebellum. 2013 Dec; 12(6):932-6.
Score: 0.005
-
Expansion of the Spinocerebellar ataxia type 10 (SCA10) repeat in a patient with Sioux Native American ancestry. PLoS One. 2013; 8(11):e81342.
Score: 0.005
-
Most expression and splicing changes in myotonic dystrophy type 1 and type 2 skeletal muscle are shared with other muscular dystrophies. Neuromuscul Disord. 2014 Mar; 24(3):227-40.
Score: 0.005
-
Mutation in the kv3.3 voltage-gated potassium channel causing spinocerebellar ataxia 13 disrupts sound-localization mechanisms. PLoS One. 2013; 8(10):e76749.
Score: 0.005
-
Diagnostic odyssey of patients with myotonic dystrophy. J Neurol. 2013 Oct; 260(10):2497-504.
Score: 0.004
-
Analysis of the visual system in Friedreich ataxia. J Neurol. 2013 Sep; 260(9):2362-9.
Score: 0.004
-
Using next-generation sequencing as a genetic diagnostic tool in rare autosomal recessive neurologic Mendelian disorders. Neurobiol Aging. 2013 Oct; 34(10):2442.e11-7.
Score: 0.004
-
Profile of the regions on the alpha-chain of human acetylcholine receptor recognized by autoantibodies in myasthenia gravis. Mol Immunol. 1992 Dec; 29(12):1507-14.
Score: 0.004
-
Anticipation in myotonic dystrophy. I. Statistical verification based on clinical and haplotype findings. Neurology. 1992 Oct; 42(10):1871-7.
Score: 0.004
-
Anticipation in myotonic dystrophy. II. Complex relationships between clinical findings and structure of the GCT repeat. Neurology. 1992 Oct; 42(10):1877-83.
Score: 0.004
-
Affective communication deficits associated with cerebellar degeneration. Neurocase. 2014; 20(1):18-26.
Score: 0.004
-
Population stratification may bias analysis of PGC-1a as a modifier of age at Huntington disease motor onset. Hum Genet. 2012 Dec; 131(12):1833-40.
Score: 0.004
-
Olfactory impairment in familial ataxias. J Neurol Neurosurg Psychiatry. 2012 Oct; 83(10):970-4.
Score: 0.004
-
TAA repeat variation in the GRIK2 gene does not influence age at onset in Huntington's disease. Biochem Biophys Res Commun. 2012 Aug 03; 424(3):404-8.
Score: 0.004
-
Friedreich ataxia clinical outcome measures: natural history evaluation in 410 participants. J Child Neurol. 2012 Sep; 27(9):1152-8.
Score: 0.004
-
CAG repeat expansion in Huntington disease determines age at onset in a fully dominant fashion. Neurology. 2012 Mar 06; 78(10):690-5.
Score: 0.004
-
Spinocerebellar ataxias: genotype-phenotype correlations in 104 Brazilian families. Clinics (Sao Paulo). 2012; 67(5):443-9.
Score: 0.004
-
Diagnostic value of ophthalmologic findings in myotonic dystrophy: comparison with risks calculated by haplotype analysis of closely linked restriction fragment length polymorphisms. Am J Med Genet. 1992 Jan 01; 42(1):55-60.
Score: 0.004
-
Mutations in the gene PRRT2 cause paroxysmal kinesigenic dyskinesia with infantile convulsions. Cell Rep. 2012 Jan 26; 1(1):2-12.
Score: 0.004
-
Objective home-based gait assessment in spinocerebellar ataxia. J Neurol Sci. 2012 Feb 15; 313(1-2):95-8.
Score: 0.004
-
Spinocerebellar ataxia type 10: disproportionate cerebellar symptoms among at-risk subjects induced by small amounts of alcohol. Arq Neuropsiquiatr. 2011 Oct; 69(5):841.
Score: 0.004
-
Confirmation of the severe phenotypic effect of serine at codon 41 of the superoxide dismutase 1 gene. Muscle Nerve. 2011 Oct; 44(4):499-502.
Score: 0.004
-
Measuring the rate of progression in Friedreich ataxia: implications for clinical trial design. Mov Disord. 2010 Mar 15; 25(4):426-32.
Score: 0.004
-
Health related quality of life measures in Friedreich Ataxia. J Neurol Sci. 2008 Sep 15; 272(1-2):123-8.
Score: 0.003
-
Clinical and molecular diagnosis of a Costa Rican family with autosomal recessive myotonia congenita (Becker disease) carrying a new mutation in the CLCN1 gene. Rev Biol Trop. 2008 Mar; 56(1):1-11.
Score: 0.003
-
Effect of skin surface temperature on transdermal absorption of flurbiprofen from a cataplasm. Chem Pharm Bull (Tokyo). 1987 Dec; 35(12):4883-90.
Score: 0.003
-
Instability of expanded CAG/CAA repeats in spinocerebellar ataxia type 17. Eur J Hum Genet. 2008 Feb; 16(2):215-22.
Score: 0.003
-
Antioxidant use in Friedreich ataxia. J Neurol Sci. 2008 Apr 15; 267(1-2):174-6.
Score: 0.003
-
Anticipation and intergenerational repeat instability in spinocerebellar ataxia type 17. Ann Neurol. 2007 Jun; 61(6):607-10.
Score: 0.003
-
Distinct distribution of autosomal dominant spinocerebellar ataxia in the Mexican population. Mov Disord. 2007 May 15; 22(7):1050-3.
Score: 0.003
-
Reduced penetrance in a Brazilian family with spinocerebellar ataxia type 10. Arch Neurol. 2007 Apr; 64(4):591-4.
Score: 0.003
-
Spastic pure motor monoparesis. Ann Neurol. 1986 Nov; 20(5):638-41.
Score: 0.003
-
Collaborative analysis of alpha-synuclein gene promoter variability and Parkinson disease. JAMA. 2006 Aug 09; 296(6):661-70.
Score: 0.003
-
Measuring Friedreich ataxia: complementary features of examination and performance measures. Neurology. 2006 Jun 13; 66(11):1711-6.
Score: 0.003
-
False positive anti-acetylcholine receptor antibodies in motorneurone disease. Lancet. 1986 May 31; 1(8492):1272.
Score: 0.003
-
Reduced penetrance of intermediate size alleles in spinocerebellar ataxia type 10. Neurology. 2006 May 23; 66(10):1602-4.
Score: 0.003
-
Complement-dependent lysis of cultured rat myotubes by myasthenic immunoglobulins. Neurology. 1985 Dec; 35(12):1748-53.
Score: 0.003
-
The hot bath test in multiple sclerosis: comparison with visual evoked responses and oligoclonal bands. Acta Neurol Scand. 1985 Jul; 72(1):65-7.
Score: 0.003
-
Measuring Friedreich ataxia: Interrater reliability of a neurologic rating scale. Neurology. 2005 Apr 12; 64(7):1261-2.
Score: 0.003
-
A rare truncating mutation in ADH1C (G78Stop) shows significant association with Parkinson disease in a large international sample. Arch Neurol. 2005 Jan; 62(1):74-8.
Score: 0.002
-
Clinical evaluation of idiopathic paroxysmal kinesigenic dyskinesia: new diagnostic criteria. Neurology. 2004 Dec 28; 63(12):2280-7.
Score: 0.002
-
Friedreich ataxia in carriers of unstable borderline GAA triplet-repeat alleles. Ann Neurol. 2004 Dec; 56(6):898-901.
Score: 0.002
-
Huntington's Disease-like 2 (HDL2) in North America and Japan. Ann Neurol. 2004 Nov; 56(5):670-4.
Score: 0.002
-
Clinical phenotype of Brazilian families with spinocerebellar ataxia 10. Neurology. 2004 Oct 26; 63(8):1509-12.
Score: 0.002
-
Minocycline in Huntington's disease: a pilot study. Mov Disord. 2004 Jun; 19(6):692-5.
Score: 0.002
-
Spinocerebellar ataxia type 8: molecular genetic comparisons and haplotype analysis of 37 families with ataxia. Am J Hum Genet. 2004 Jul; 75(1):3-16.
Score: 0.002
-
Germline mutational dynamics in myotonic dystrophy type 1 males: allele length and age effects. Neurology. 2004 Jan 27; 62(2):269-74.
Score: 0.002
-
[Significance of time-lapse changes in gallium-67 citrate accumulation in the diagnosis of hepatoma]. Kaku Igaku. 1983 Dec; 20(10):1449-58.
Score: 0.002
-
Huntington's disease--like 2 can present as chorea-acanthocytosis. Neurology. 2003 Oct 14; 61(7):1002-4.
Score: 0.002
-
Haplotype analysis of the ETM2 locus in familial essential tremor. Neurogenetics. 2003 Aug; 4(4):185-9.
Score: 0.002
-
A dominantly inherited syndrome with continuous motor neuron discharges. Ann Neurol. 1983 Mar; 13(3):285-90.
Score: 0.002
-
[CT images of diffuse hepatic disease]. Rinsho Hoshasen. 1982 Dec; 27(13):1411-6.
Score: 0.002
-
Instability of a premutation allele in homozygous patients with myotonic dystrophy type 1. Ann Neurol. 2002 Oct; 52(4):435-41.
Score: 0.002
-
Association of homozygous 7048G7049 variant in the intron six of Nurr1 gene with Parkinson's disease. Neurology. 2002 Mar 26; 58(6):881-4.
Score: 0.002
-
Clinical and genetic analysis of four Mexican families with spinocerebellar ataxia type 10. Ann Neurol. 2001 Aug; 50(2):234-9.
Score: 0.002
-
Paroxysmal kinesigenic dyskinesia and infantile convulsions: clinical and linkage studies. Neurology. 2000 Jul 25; 55(2):224-30.
Score: 0.002
-
An interrupted 34-CAG repeat SCA-2 allele in patients with sporadic spinocerebellar ataxia. Neurology. 2000 Jan 25; 54(2):491-3.
Score: 0.002
-
[Prediction of the clinical efficacy of hepatic arterial chemotherapy for metastatic hepatic cancer by intraarterial infusion of 99mTc-MIBI]. Kaku Igaku. 2000 Jan; 37(1):29-33.
Score: 0.002
-
Immunohistochemical and molecular analysis of giant cell carcinoma of the pancreas: a report of three cases. Pancreas. 1999 Apr; 18(3):308-15.
Score: 0.002
-
[Nurses' knowledge of alcohol-related problems and their treatment: a comparison of nurses in general hospital and alcoholism treatment units]. Nihon Arukoru Yakubutsu Igakkai Zasshi. 1998 Dec; 33(6):671-82.
Score: 0.002
-
Atypical Friedreich ataxia caused by compound heterozygosity for a novel missense mutation and the GAA triplet-repeat expansion. Am J Hum Genet. 1997 May; 60(5):1251-6.
Score: 0.001
-
Autosomal dominant cerebellar ataxia (SCA6) associated with small polyglutamine expansions in the alpha 1A-voltage-dependent calcium channel. Nat Genet. 1997 Jan; 15(1):62-9.
Score: 0.001
-
Molecular detection of new mutations, resolution of ambiguous results and complex genetic counseling issues in Huntington disease. Am J Med Genet. 1996 Dec 18; 66(3):281-6.
Score: 0.001
-
Myotonic dystrophy phenotype without expansion of (CTG)n repeat: an entity distinct from proximal myotonic myopathy (PROMM)? J Neurol. 1996 Oct; 243(10):715-21.
Score: 0.001
-
Cardiac involvement in a large kindred with myotonic dystrophy. Quantitative assessment and relation to size of CTG repeat expansion. JAMA. 1995 Sep 13; 274(10):813-9.
Score: 0.001
-
Effect of myotonic dystrophy trinucleotide repeat expansion on DMPK transcription and processing. Genomics. 1995 Jul 01; 28(1):1-14.
Score: 0.001
-
Somatic mosaicism, germline expansions, germline reversions and intergenerational reductions in myotonic dystrophy males: small pool PCR analyses. Hum Mol Genet. 1995 Jan; 4(1):1-8.
Score: 0.001
-
Somatic heterogeneity of the CTG repeat in myotonic dystrophy is age and size dependent. Am J Hum Genet. 1995 Jan; 56(1):114-22.
Score: 0.001
-
Antitumor effect of KT6124, a novel derivative of protein kinase inhibitor K-252a, and its mechanism of action. Cancer Chemother Pharmacol. 1992; 29(4):266-72.
Score: 0.001
-
Clinical features of Todd's post-epileptic paralysis. J Neurol Neurosurg Psychiatry. 1992 Jan; 55(1):63-4.
Score: 0.001
-
Cerebral vasculitis in relapsing polychondritis. Neurology. 1988 Jan; 38(1):150-2.
Score: 0.001
-
Progressive multifocal leukoencephalopathy and magnetic resonance imaging. Ann Neurol. 1986 Apr; 19(4):399-401.
Score: 0.001
-
Ligation and catheterization of the hepatic artery for palliative treatment of malignant hepatic tumors. J Surg Oncol. 1983 Aug; 23(4):219-22.
Score: 0.001